VACBF (Nykode Therapeutics AS) Common Stock : $0.37 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Common Stock?

Nykode Therapeutics AS's quarterly common stock stayed the same from Mar. 2024 ($0.37 Mil) to Jun. 2024 ($0.37 Mil) and stayed the same from Jun. 2024 ($0.37 Mil) to Sep. 2024 ($0.37 Mil).

Nykode Therapeutics AS's annual common stock increased from Dec. 2021 ($0.33 Mil) to Dec. 2022 ($0.34 Mil) and increased from Dec. 2022 ($0.34 Mil) to Dec. 2023 ($0.37 Mil).

Nykode Therapeutics AS Common Stock Historical Data

The historical data trend for Nykode Therapeutics AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Common Stock Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.32

0.33

0.34

0.37

Nykode Therapeutics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															0.34	0.37	0.37	0.37	0.37

Nykode Therapeutics AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.